PBM Capital Group Acquires Breas Medical from GE Healthcare
Search
Share on twitter
Share on linkedin
Share on print
Share on email

PBM Capital Group Acquires Breas Medical from GE Healthcare

breas nfPBM Capital Group has acquired Breas Medical AB, a manufacturer of home respiratory ventilators, from GE Healthcare, a subsidiary of General Electric Company.

Breas Medical is a manufacturer of home respiratory ventilators and sleep apnea products. Products are sold directly through Breas and in more than 40 countries through a global network of distributors. Breas employs more than 100 people in nine countries and operates a 30,000 square-foot manufacturing and office facility (headquarters) near Gothenberg in Molnlycke, Sweden. Breas is led by its CEO, Nicke Svanvik. Breas was founded in 1991 and was acquired by GE Healthcare in 2008 (www.breas.com).

PBM Capital will integrate Breas into its existing portfolio company Human Design Medical (HDM), a medical device company focusing on the treatment of sleep apnea. In November 2013, HDM released the Z1, which the company claims is the world’s smallest and lightest continuous positive airway pressure (CPAP) machine.

“We acquired Breas because it is a logical fit with our growing HDM sleep apnea business,” said PBM Capital Group CEO Paul B. Manning. “HDM’s Z1 CPAP machine has had an incredible launch here in the United States, and we have more innovative products in the pipeline. The Breas acquisition opens the door to global distribution channels and gives us immediate access to an established line of home care ventilators backed by a strong intellectual products portfolio. We are very excited to merge these two great companies.”

PBM Capital Group makes investments in the healthcare and life science sectors. The firm invests across all stages of corporate development including venture capital, leveraged buyouts, growth capital, distressed/turnaround, and public equities. PBM Capital was founded and is led by Paul B. Manning, an entrepreneur who sold PBM Products, an infant formula and nutrition business, to Perrigo Company in March 2010 for approximately $800 million. The firm is headquartered in Charlottesville, VA and has an additional office in New York (www.pbmcap.com).

© 2014 PEPD • Private Equity’s Leading News Magazine • 2-5-14

Share on twitter
Share on linkedin
Share on print
Share on email

To search in site, type your keyword and hit enter